Research Article
No access
Published Online: 22 August 2005

Evaluation of Beta-Absorbed Fractions in a Mouse Model for 90Y, 188Re, 166Ho, 149Pm, 64Cu, and 177Lu Radionuclides

Publication: Cancer Biotherapy & Radiopharmaceuticals
Volume 20, Issue Number 4

Abstract

Several short-lived, high-energy beta emitters are being proposed as the radionuclide components for molecular- targeted potential cancer therapeutic agents. The laboratory mice used to determine the efficacy of these new agents have organs that are relatively small compared to the ranges of these high-energy particles. The dosimetry model developed by Hui et al. was extended to provide realistic beta-dose estimates for organs in mice that received therapeutic radiopharmaceuticals containing 90Y, 188Re, 166Ho, 149Pm, 64Cu, and 177Lu. Major organs in this model included the liver, spleen, kidneys, lungs, heart, stomach, small and large bowel, thyroid, pancreas, bone, marrow, carcass, and a 0.025-g tumor. The study as reported in this paper verifies their results for 90Y and extends them by using their organ geometry factors combined with newly calculated organ self-absorbed fractions from PEREGRINE and MCNP. PEREGRINE and MCNP agree to within 8% for the worst-case organ with average differences (averaged over all organs) decreasing from 5% for 90Y to 1% for 177Lu. When used with typical biodistribution data, the three different models predict doses that are in agreement to within 5% for the worst-case organ. The beta-absorbed fractions and cross-organ–deposited energy provided in this paper can be used by researchers to predict mouse-organ doses and should contribute to an improved understanding of the relationship between dose and radiation toxicity in mouse models where use of these isotopes is favorable.

Get full access to this article

View all available purchase options and get full access to this article.

Information & Authors

Information

Published In

cover image Cancer Biotherapy and Radiopharmaceuticals
Cancer Biotherapy & Radiopharmaceuticals
Volume 20Issue Number 4August 2005
Pages: 436 - 449
PubMed: 16114992

History

Published online: 22 August 2005
Published in print: August 2005

Permissions

Request permissions for this article.

Authors

Affiliations

William H. Miller
Nuclear Science and Engineering Institute, University of Missouri, Columbia, MO.
Christine Hartmann-Siantar
Glenn T. Seaborg Institute, University of California Lawrence Livermore National Laboratory, Livermore, CA.
Department of Radiation Oncology, Cancer Center, University of California—Davis, Sacramento, CA.
Darrell Fisher
Radioisotopes Program, Pacific Northwest National Laboratory, Richland, WA.
Marie-Anne Descalle
Glenn T. Seaborg Institute, University of California Lawrence Livermore National Laboratory, Livermore, CA.
Tom Daly
Glenn T. Seaborg Institute, University of California Lawrence Livermore National Laboratory, Livermore, CA.
Joerg Lehmann
Glenn T. Seaborg Institute, University of California Lawrence Livermore National Laboratory, Livermore, CA.
Department of Radiation Oncology, Cancer Center, University of California—Davis, Sacramento, CA.
Michael R. Lewis
Veterinary Medicine and Surgery, University of Missouri, Columbia, MO.
Research Services, H.S. Truman Memorial V.A. Hospital, Columbia, MO.
Timothy Hoffman
Research Services, H.S. Truman Memorial V.A. Hospital, Columbia, MO.
Internal Medicine, University of Missouri, Columbia, MO.
Jeff Smith
Research Services, H.S. Truman Memorial V.A. Hospital, Columbia, MO.
Department of Radiology, University of Missouri, Columbia, MO.
Peter D. Situ
Nuclear Science and Engineering Institute, University of Missouri, Columbia, MO.
Research Services, H.S. Truman Memorial V.A. Hospital, Columbia, MO.
Wynn A. Volkert
Nuclear Science and Engineering Institute, University of Missouri, Columbia, MO.
Research Services, H.S. Truman Memorial V.A. Hospital, Columbia, MO.
Department of Radiology, University of Missouri, Columbia, MO.

Metrics & Citations

Metrics

Citations

Export citation

Select the format you want to export the citations of this publication.

View Options

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.

Society Access

If you are a member of a society that has access to this content please log in via your society website and then return to this publication.

Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

View options

PDF/EPUB

View PDF/EPUB

Figures

Tables

Media

Share

Share

Copy the content Link

Share on social media

Back to Top